Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Newell

Showing results (31-40 of 215) with videos related to

Pageof 22
Sort By:
Clinical Endocrinology|November 6, 2025
Efficacy and Tolerability of Metyrapone in Mild Autonomous Cortisol Secretion: Real-World Findings From Clinical PracticeSimon Berry, Ahmed Iqbal, John Newell-Price, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2021
Approach to the Patient Treated with Steroidogenesis InhibitorsFrederic Castinetti, Lynnette K Nieman, Martin Reincke, et al.
Endocrine|June 20, 2023
COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disordersAlessia Cozzolino, Valeria Hasenmajer, John Newell-Price, et al.
European Journal of Endocrinology|May 8, 2020
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndromeJohn Newell-Price, Lynnette K Nieman, Martin Reincke, et al.
Clinical Endocrinology|November 6, 2025
Benign Adrenal Adenomas Are Associated With Reduced Prevalence of Hospitalised Patients With COVID-19Alan Kelsall, Chris Johns, Eleanor Hills, et al.
Lancet (London, England)|May 16, 2006
Cushing's syndromeJohn Newell-Price, Xavier Bertagna, Ashley B Grossman, et al.
Statistical Methods in Medical Research|June 26, 2016
Estimating average attributable fractions with confidence intervals for cohort and case-control studiesJohn Ferguson, Alberto Alvarez-Iglesias, John Newell, et al.
Clinical Endocrinology|December 20, 2007
Continuous glucose monitoring in patients with insulinomaAlia Munir, Pratik Choudhary, Barney Harrison, et al.
The Oncologist|June 26, 2010
Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage diseaseHelen M Heneghan, Nicola Miller, Ronan Kelly, et al.
Breast (Edinburgh, Scotland)|May 7, 2013
Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysisHelen Ingoldsby, Mark Webber, Deirdre Wall, et al.
Pageof 22

Showing results (31-40 of 215) with videos related to

Sort By:
Pageof 22
Clinical Endocrinology|November 6, 2025
Efficacy and Tolerability of Metyrapone in Mild Autonomous Cortisol Secretion: Real-World Findings From Clinical PracticeSimon Berry, Ahmed Iqbal, John Newell-Price, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2021
Approach to the Patient Treated with Steroidogenesis InhibitorsFrederic Castinetti, Lynnette K Nieman, Martin Reincke, et al.
Endocrine|June 20, 2023
COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disordersAlessia Cozzolino, Valeria Hasenmajer, John Newell-Price, et al.
European Journal of Endocrinology|May 8, 2020
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndromeJohn Newell-Price, Lynnette K Nieman, Martin Reincke, et al.
Clinical Endocrinology|November 6, 2025
Benign Adrenal Adenomas Are Associated With Reduced Prevalence of Hospitalised Patients With COVID-19Alan Kelsall, Chris Johns, Eleanor Hills, et al.
Lancet (London, England)|May 16, 2006
Cushing's syndromeJohn Newell-Price, Xavier Bertagna, Ashley B Grossman, et al.
Statistical Methods in Medical Research|June 26, 2016
Estimating average attributable fractions with confidence intervals for cohort and case-control studiesJohn Ferguson, Alberto Alvarez-Iglesias, John Newell, et al.
Clinical Endocrinology|December 20, 2007
Continuous glucose monitoring in patients with insulinomaAlia Munir, Pratik Choudhary, Barney Harrison, et al.
The Oncologist|June 26, 2010
Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage diseaseHelen M Heneghan, Nicola Miller, Ronan Kelly, et al.
Breast (Edinburgh, Scotland)|May 7, 2013
Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysisHelen Ingoldsby, Mark Webber, Deirdre Wall, et al.
Pageof 22